OpenURL Connection Search

Select item for more details and to access through your institution.

Phenothiazines induce PP2A-mediated apoptosis in T cell acute lymphoblastic leukemia.
Published in:
Journal of Clinical Investigation, 2014, v. 124, n. 2, p. 644, doi. 10.1172/JCI65093
By:
- Gutierrez, Alejandro;
- Li Pan;
- Groen, Richard W. J.;
- Baleydier, Frederic;
- Kentsis, Alex;
- Marineau, Jason;
- Grebliunaite, Ruta;
- Kozakewich, Elena;
- Reed, Casie;
- Pflumio, Francoise;
- Poglio, Sandrine;
- Uzan, Benjamin;
- Clemons, Paul;
- VerPlank, Lynn;
- An, Frank;
- Burbank, Jason;
- Norton, Stephanie;
- Tolliday, Nicola;
- Steen, Hanno;
- Weng, Andrew P.
Publication type:
Article
In vivo <sup>18</sup>F‐fluoride‐PET imaging reveals pronounced heterogeneity in bone formation in multiple myeloma patients.
Published in:
British Journal of Haematology, 2023, v. 200, n. 6, p. 755, doi. 10.1111/bjh.18588
By:
- Regelink, Josien C.;
- Zwezerijnen, Gerben J. C.;
- Groen, Richard J. W.;
- Raijmakers, Pieter G.;
- Zweegman, Sonja
Publication type:
Article
Transcriptional Silencing of the Wnt-Antagonist DKK1 by Promoter Methylation Is Associated with Enhanced Wnt Signaling in Advanced Multiple Myeloma.
Published in:
PLoS ONE, 2012, v. 7, n. 2, p. 1, doi. 10.1371/journal.pone.0030359
By:
- Kocemba, Kinga A.;
- Groen, Richard W. J.;
- Andel, Harmen van;
- Kersten, Marie José;
- Mahtouk, Karène;
- Spaargaren, Marcel;
- Pals, Steven T.
Publication type:
Article
Lenalidomide for the treatment of relapsed and refractory multiple myeloma.
Published in:
Cancer Management & Research, 2012, v. 4, p. 253, doi. 10.2147/CMAR.S27087
By:
- Van de Donk, Niels W. C. J.;
- Görgün, Güllü;
- Groen, Richard W. J.;
- Jakubikova, Jana;
- Mitsiades, Constantine S.;
- Hideshima, Teru;
- Laubach, Jacob;
- Nijhof, Inger S.;
- Raymakers, Reinier A.;
- Lokhorst, Henk M.;
- Richardson, Paul G.;
- Anderson, Kenneth C.
Publication type:
Article

Found: 4

Phenothiazines induce PP2A-mediated apoptosis in T cell acute lymphoblastic leukemia.

In vivo <sup>18</sup>F‐fluoride‐PET imaging reveals pronounced heterogeneity in bone formation in multiple myeloma patients.

Transcriptional Silencing of the Wnt-Antagonist DKK1 by Promoter Methylation Is Associated with Enhanced Wnt Signaling in Advanced Multiple Myeloma.

Lenalidomide for the treatment of relapsed and refractory multiple myeloma.